Financial Shenanigans

Figures converted from INR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

The Forensic Verdict

Vedanta screens as Elevated forensic risk: the reported cash generation is real enough to avoid a harsher grade, but the accounting perimeter and related-party economics require a valuation haircut. The top two concerns are the promoter/related-party cash-transfer architecture and the FY2026 shift between reported statement revenue and management's record-revenue framing around discontinued operations and the demerger. The cleanest offsetting evidence is cash conversion: over FY2024-FY2026, operating cash flow was 2.16x net income and free cash flow was 1.14x net income. The data point that would most change the grade is a fully audited FY2026 demerger bridge that reconciles continuing operations, discontinued operations, EBITDA, brand fees, related-party loans, and receivable recoverability without a new control qualification.

Breeding Ground

The breeding ground amplifies the accounting risk because Vedanta combines promoter control, material related-party economics, and a prior control finding, even though the latest statutory audit opinion is clean.

The most important breeding-ground fact is not a generic promoter discount; it is the linkage between FY2021's control weakness over related-party loans and guarantees and FY2025's continuing material brand fees, holding-company dividends, and related-party loan balances. The clean counterweight is that the FY2025 statutory auditors issued an unmodified opinion and reported no fraud to the audit committee.

Earnings Quality

Earnings quality is mixed: aggregate receivables and debtor days do not show broad premature revenue, but disputed receivables, exceptional items, and FY2026 presentation shifts make headline earnings less clean than cash conversion alone suggests.

Revenue grew 6.3% in FY2025 while trade receivables grew only 1.2%, and debtor days stayed at 9 days. That is a clean aggregate revenue test. The caveat is quality within receivables: the auditors called out $0.27B of disputed power receivables as a key audit matter, with recoverability dependent on regulatory, legal, and counterparty outcomes.

Other income is the earnings-quality pressure point in FY2026: it rises to $1.51B, equal to 61% of operating income, while statement revenue drops sharply. That pattern is not proof of manipulation, but it means FY2026 net income needs a line-by-line bridge before it is treated as recurring operating earnings.

FY2025 capitalization does not look like a standalone shenanigan: CWIP rose with a visible growth-capex program, while depreciation increased only 3% in the annual report. FY2026 is different: fixed assets fall to $3.28B and other assets jump to $18.84B, which is almost certainly a demerger/discontinued-operations classification issue that investors must reconcile before comparing margins or asset turns.

Cash Flow Quality

Cash flow quality is the strongest offsetting evidence: operating cash flow has consistently exceeded net income, and FY2025 working capital did not flatter cash generation.

FY2024-FY2026 CFO totals $11.11B against net income of $5.98B, and FCF totals $6.96B. That is not the pattern of earnings being broadly manufactured through accruals. The remaining concern is use of cash: dividends, parent-level deleveraging, and related-party economics absorb a large share of the cash the operations generate.

FY2025 cash flow was not propped up by stretching suppliers: receivable collection added $0.65B, but inventory and payables together consumed $0.73B, leaving a net working-capital outflow of $0.08B. The borrowings note also shows amounts due on factoring were zero at FY2025 year-end, versus only $0.003B in FY2024, so there is no material factoring signal in the available filing.

The clean test is negative accruals in every recent year. The less clean test is management's preference for "FCF pre-capex" in presentations; FY2026 pre-capex free cash flow of $2.77B is not the same as statement FCF of $2.00B after capex.

Metric Hygiene

Metric hygiene is the main red flag because management's preferred FY2026 story uses record all-segment revenue and EBITDA while the financial statement dataset reflects a much smaller continuing-revenue base.

This is the report's most important metric-hygiene issue. The FY2026 presentation describes record revenue of $18.56B and EBITDA of $5.97B, while the financial statement dataset shows revenue of $8.36B and net income of $2.68B. The likely driver is demerger and discontinued-operations presentation, not necessarily manipulation, but it is a high-risk comparability break.

The metric problem is not that EBITDA or PAT before exceptional items are invalid. It is that Vedanta's FY2026 demerger context makes those metrics easy to misread unless the investor rebuilds continuing operations, discontinued operations, intercompany eliminations, and demerged entity debt by hand.

What to Underwrite Next

The next underwriting work should focus on five exact disclosures that can move the grade up or down, not on a generic accounting-risk checklist.

1. FY2026 audited demerger bridge: monitor continuing revenue, discontinued revenue, EBITDA, PAT, assets, liabilities, and intercompany eliminations. Downgrade if the bridge leaves unexplained revenue or asset gaps; upgrade if it ties presentation metrics to audited statements without residual plugs.

2. Related-party economics: monitor management and brand fees, strategic service fees, related-party loans, guarantees, and dividends to holding companies. Downgrade if fees, loans, or guarantees rise without clear arm-length economics; upgrade if fees fall, loans amortize, and independent approval detail improves.

3. Power receivable recoverability: monitor disputed receivables, ECL, PSPCL and GRIDCO litigation status, and aging over 3 years. Downgrade if ECL rises or legal assumptions weaken; upgrade if cash collection reduces disputed balances without new concessions.

4. Cash-flow definition discipline: monitor CFO, capex, FCF after capex, FCF pre-capex, acquisitions, disposals, and OFS proceeds. Downgrade if deleveraging depends on disposals while operating FCF falls; upgrade if FCF after capex funds dividends and debt reduction without asset sales.

5. Auditor and control language: monitor audit opinion, internal financial controls, key audit matters, auditor changes, and non-audit fee disclosure. Downgrade if any control qualification returns, especially around related parties; upgrade if the new auditor cycle confirms clean controls and narrows KAMs.

This forensic work should affect valuation and position sizing, not kill the thesis by itself. Strong CFO and negative accruals argue against treating the numbers as broadly unreliable, but promoter-related cash flows, disputed receivables, and FY2026 metric discontinuity warrant a higher margin of safety until the demerger bridge and related-party schedule are audit-clean and easy to reconcile.